TERF2 and central nervous system cancer: Researchers found that downregulation of Pdcd4 facilitates glioblastoma proliferation in vivo31, the SIRT1 activator SRT2183 suppresses glioma cell growth32, and molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells33.